search
Back to results

A Randomized, Controlled, Unblinded, Clinical Trial of the Acceptability and Efficacy of Non-Pharmaceutical Methods in Preventing Spread of Influenza Within the Family

Primary Purpose

Influenza

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
sanitation and personal hygiene
Sponsored by
Ministry of Health, Israel
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional prevention trial for Influenza

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All Sexes

Inclusion Criteria:

  • Family members of an index case with influenza-like illness (ILI) during the first two days of his illness.
  • No limitations will be given regarding the number of family members.

Exclusion Criteria:

  • Presence of another household member with ILI during the previous two weeks.

Sites / Locations

    Outcomes

    Primary Outcome Measures

    secondary infection of influenza within the family

    Secondary Outcome Measures

    compliance of non-pharmaceutical interventions

    Full Information

    First Posted
    December 11, 2006
    Last Updated
    December 11, 2006
    Sponsor
    Ministry of Health, Israel
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT00410176
    Brief Title
    A Randomized, Controlled, Unblinded, Clinical Trial of the Acceptability and Efficacy of Non-Pharmaceutical Methods in Preventing Spread of Influenza Within the Family
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    December 2006
    Overall Recruitment Status
    Unknown status
    Study Start Date
    January 2007 (undefined)
    Primary Completion Date
    undefined (undefined)
    Study Completion Date
    undefined (undefined)

    3. Sponsor/Collaborators

    Name of the Sponsor
    Ministry of Health, Israel

    4. Oversight

    5. Study Description

    Brief Summary
    The proposed study will evaluate whether the use of non-pharmaceutical methods, such as surgical masks, isolation of patients and personal hygiene, are acceptable and effective in preventing the spread of influenza within the family.This will be achieved by conducting a randomized, controlled, unblinded, clinical trial. Family members of an index case with influenza like illness, will be randomly allocated to two groups. In the intervention group, family members will receive comprehensive guidance about sanitation and hygiene, as well as surgical masks to wear whenever in close contact (3 feet / 1 meter) with the index case. In addition, they will be asked to isolate the index case as much as possible. In the control group, family members will receive only standard guidance about sanitation and hygiene relevant for reducing the transmission of influenza. The primary end-point of the study will be secondary infection of influenza of at least one of the family members in order to asses the efficacy of the interventions. In addition, the compliance to those interventions will be evaluated. The study hypothesis is that use of non-pharmaceutical methods will be acceptable and will reduce the secondary infection rate among them by 50%.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Influenza

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    400 (false)

    8. Arms, Groups, and Interventions

    Intervention Type
    Behavioral
    Intervention Name(s)
    sanitation and personal hygiene
    Primary Outcome Measure Information:
    Title
    secondary infection of influenza within the family
    Secondary Outcome Measure Information:
    Title
    compliance of non-pharmaceutical interventions

    10. Eligibility

    Sex
    All
    Eligibility Criteria
    Inclusion Criteria: Family members of an index case with influenza-like illness (ILI) during the first two days of his illness. No limitations will be given regarding the number of family members. Exclusion Criteria: Presence of another household member with ILI during the previous two weeks.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Manfred S Green, PhD, M.D
    Phone
    972-3-7371500
    Ext
    203
    Email
    m.green@icdc.health.gov.il
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Manfred S Green, PhD, M.D
    Organizational Affiliation
    ICDC
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Learn more about this trial

    A Randomized, Controlled, Unblinded, Clinical Trial of the Acceptability and Efficacy of Non-Pharmaceutical Methods in Preventing Spread of Influenza Within the Family

    We'll reach out to this number within 24 hrs